Embolic Protection Devices Market Size, Share & Trends Analysis Report By Device Type (Proximal Occlusion systems, Distal Occlusion Systems, Distal Filters), By Application (Cardiovascular Diseases, Neurovascular Diseases, Peripheral Vascular Diseases), By End-User (Hospitals, Ambulatory Surgery Centres) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Embolic Protection Devices Market Size

The global embolic protection devices market size was valued at USD 777.1 million in 2025 and is projected to grow from USD 830.10 million in 2026 to USD 1407.18 million by 2034, registering a CAGR of 6.82% during the forecast period from 2026 to 2034. North America dominated the embolic protection devices market with a market share of 39.2% in 2025.

The embolic protection devices (EPD) market is experiencing significant growth, driven by factors such as the increasing prevalence of cardiovascular, neurovascular, and peripheral vascular diseases, ongoing technological advancements, and a growing preference for minimally invasive procedures. These devices play a crucial role in improving procedural safety by capturing and extracting embolic debris produced during interventions, thereby reducing the risk of complications such as stroke.

In the context of cardiovascular diseases, embolic protection devices are commonly used during procedures like carotid artery stenting, transcatheter aortic valve replacement (TAVR), and coronary interventions. TAVR, a minimally invasive procedure for treating valve diseases, particularly benefits from these devices, as they help reduce the risk of stroke and other complications by preventing embolic particles from reaching critical areas.

Similarly, in patients with neurovascular conditions, including ischemic stroke and transient ischemic attacks (TIAs), cerebral embolic protection devices (CEPD) are employed to prevent ischemic brain damage during TAVR. These devices capture embolic particles, ensuring that the brain is protected from potential harm during the procedure.

• A recent study published by the American Heart Association in June 2024 found that 12.9% of 414,649 TAVR patients were treated with embolic protection devices. The results highlighted that patients using EPDs had a lower risk of disabling strokes compared to those who did not, underscoring the importance of these devices in enhancing patient outcomes.

As embolic protection devices become increasingly integral to modern interventional cardiology and vascular surgery, their market growth will continue to be driven by ongoing research, regulatory approvals, and strategic investments. The adoption of these devices is expected to expand, further solidifying their role in reducing stroke risk and improving the safety of key medical procedures.

Device Type Insights

The distal filter segment holds the largest market share due to its widespread use in treating carotid artery stenosis, strokes, deep vein thrombosis, and pulmonary embolism. These filters effectively capture embolic debris, reducing the risk of complications during vascular procedures. Moreover, advancements like transfemoral carotid artery stenting (tfCAS) further enhance their adoption.

• According to a Journal of Vascular Surgery article (June 2023), distal embolic protection filters were used in 95% of 29,853 tfCAS patients, significantly lowering in-hospital stroke and mortality rates compared to those without filters.

Request Customizationto receive a tailored report.

Application Insights

The cardiovascular diseases segment leads the market due to the rising prevalence of conditions like carotid artery disease, aortic valve disease, coronary artery disease, and peripheral artery disease. The effectiveness of embolic protection therapies in preventing stroke and improving patient outcomes further drives demand.

• As per an April 2024 Journal of the American College of Cardiology report, there were 315 million prevalent cases of coronary artery disease (CAD) worldwide in 2022, highlighting the growing need for embolic protection devices in cardiovascular procedures.

End-User Insights

Hospitals dominate the market due to their advanced infrastructure, access to specialized healthcare professionals, and ability to provide comprehensive patient care. With the increasing number of cardiovascular procedures, hospitals remain the primary end-users of embolic protection devices.

• According to Spectrum News (July 2024), the U.S. has seen a rise in specialized heart hospitals, with U.S. News & World Report ranking in the top 50 out of nearly 800 institutions based on quality-of-care measures and patient satisfaction, reinforcing hospitals' critical role in market expansion.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America holds the largest share in the global embolic protection devices market, driven by its advanced healthcare infrastructure, high prevalence of cardiovascular and neurological disorders, and significant investments in research and development. The region benefits from well-established reimbursement policies that facilitate the adoption of innovative medical technologies.

Moreover, the presence of major industry players, growing awareness of embolic protection therapies, and a strong regulatory framework supporting new device approvals further solidify North America’s leadership. The rising number of transcatheter aortic valve replacement (TAVR) and carotid artery stenting (CAS) procedures also contributes to market expansion.

The U.S. embolic protection devices market is expanding due to the rising prevalence of cardiovascular diseases and the adoption of advanced medical technologies. In October 2024, the CDC reported that heart disease accounted for 702,880 deaths in 2022, making it the leading cause of death. With growing demand for innovative cardiovascular solutions, the market is set for continued growth, improving patient outcomes and advancing embolic protection technologies.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Embolic Protection Devices Market Trends

Asia-Pacific is expected to experience the fastest CAGR in the global embolic protection devices market due to increasing investments in healthcare infrastructure and the rising prevalence of cardiovascular diseases. Countries like China, Japan, and India are witnessing rapid advancements in medical technology and an expanding patient base requiring embolic protection. Government initiatives promoting minimally invasive procedures, increasing clinical trials, and improving healthcare accessibility further drive market growth.

China's market is expanding due to the growing burden of cardiovascular diseases and government-backed medical innovations. Faster regulatory approvals and advancements in healthcare technology are driving adoption. The increasing focus on safer and more efficient cardiovascular interventions, particularly in transcatheter procedures, is propelling market growth and improving patient care, making China a key player in the global embolic protection devices industry.

Australia is actively embracing embolic protection devices to enhance patient safety in cardiovascular treatments. In November 2024, Endovascular Today reported that Arsenal Medical launched the EMBO-02 clinical trial to evaluate its NeoCast liquid embolic for treating chronic subdural hematomas. This commitment to medical innovation is driving market growth, expanding treatment options, and improving cardiovascular intervention outcomes across the country.

Europe Embolic Protection Devices Market Trends

Germany’s embolic protection devices industry is expanding and is driven by leading medical manufacturers and a highly advanced healthcare system. In February 2025, World Business Outlook highlighted ProtEmbo, an intra-aortic filter developed by Protembis GmbH, which reduces stroke risk during transcatheter aortic valve implantation (TAVI). As new cardiovascular technologies gain traction, Germany is fostering market growth, improving procedural success rates, and enhancing patient safety in high-risk cardiovascular interventions.

Latam Embolic Protection Devices Market Trends

Brazil’s market is rising due to the increasing prevalence of cardiovascular diseases and advancements in medical technology. With greater investment in healthcare infrastructure and a shift towards sophisticated treatment options, the adoption of embolic protection devices is improving patient outcomes. As the country continues to develop its cardiovascular care capabilities, the market is expected to witness steady expansion in the coming years.

List of Key and Emerging Players in Embolic Protection Devices Market